PTPRK and malignant colon neoplasm: Their mechanism of action has been reported as the downregulation of protein tyrosine phosphatase receptor type K (PTPRK) in vitro, since PTPRK is a tumor suppressor gene product that may be involved in colon cancer [516,561,562,563].